Study guide

6.3 Tc-99m GI and Hepatobiliary Agents

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

6.3 Tc-99m GI and Hepatobiliary Agents

Key Takeaways Explain This Topic AI

Tc-99m mebrofenin (Choletec®) is an IDA (HIDA) agent taken up by hepatocytes and excreted into bile—used for acute cholecystitis, biliary patency, and bile leaks

HIDA patients are typically NPO about 4–6 hours (not prolonged days of fasting); morphine and CCK (sincalide) are common adjuncts

Tc-99m sulfur colloid is phagocytized by RES (liver, spleen, bone marrow); uses include liver-spleen scan, gastric emptying (meal labeling), and lymphoscintigraphy (filtered)

Tc-99m pertechnetate is trapped by gastric mucosa (Meckel’s diverticulum) and thyroid/salivary tissue; not an organified thyroid hormone analog like iodine

Know particle size: unfiltered sulfur colloid for RES liver-spleen; filtered smaller particles for lymph studies

Last updated: August 2026

6.3 Tc-99m GI and Hepatobiliary Agents

Quick Answer: Mebrofenin (HIDA) → hepatocyte uptake and biliary excretion (NPO ~4–6 h; morphine/CCK adjuncts). Sulfur colloid → RES phagocytosis (liver-spleen, gastric emptying meals, filtered lymph). Pertechnetate → trapping in gastric mucosa (Meckel’s) and thyroid. Match prep and particle size to the study.

  • Hepatobiliary Imaging: Tc-99m Mebrofenin (Choletec®)
  • Mechanism

Tc-99m mebrofenin is an iminodiacetic acid ( IDA ) analog—often still called a “HIDA scan” generically. After IV injection it is extracted from blood by hepatocytes and excreted into bile canaliculi , filling ducts, gallbladder (if cystic duct is patent), and bowel. It is not a RES colloid and should not light up spleen like sulfur colloid.

Exam language may say “IDA/HIDA agent” interchangeably with mebrofenin; mebrofenin performs relatively well at higher bilirubin levels.

Indications

Acute cholecystitis (cystic duct obstruction—nonvisualized gallbladder with adequate hepatic excretion), biliary dyskinesia with ejection fraction (CCK), bile leak, and pediatric biliary atresia vs neonatal hepatitis workups.

Dose, Route, Imaging

  • Item Typical practice
  • Activity ~3–10 mCi (111–370 MBq) IV (adult; higher end sometimes if bilirubin elevated—follow protocol)
  • Route Intravenous
  • Dynamic imaging Continuous or serial images 0–60 min; delayed views as needed
  • Normal pattern Liver → ducts → gallbladder → bowel within ~60 min (lab-specific criteria)
  • Patient Prep — NPO Rules

Patients are usually NPO about 4–6 hours before injection. A recent meal leaves the gallbladder contracted from endogenous CCK and causes false nonvisualization of an otherwise patent cystic duct. Prolonged fasting (>24 h) or TPN packs the gallbladder with viscous bile that may not fill either—some protocols pretreat with CCK to empty it first. Document opioids and other sphincter of Oddi / gallbladder-active medications; they change filling kinetics and morphine-augmentation decisions.

Adjuncts (Intro-Level)

Adjunct Role

Morphine Contracts sphincter of Oddi; diverts bile into GB if cystic duct patent when GB unseen but duct/bowel activity present

  • CCK (sincalide) GB contraction for ejection fraction ; may empty GB after prolonged fasting
  • Phenobarbital (peds) Enzyme induction in neonatal cholestasis protocols

Know why morphine or CCK is given—not every milligram schedule.

HIDA Traps

Do not confuse nonvisualization from poor hepatic function with cystic duct obstruction. Do not expect a hot spleen (wrong agent class). Recent fatty meal invalidates prep.

  • Tc-99m Sulfur Colloid
  • Mechanism

Tc-99m sulfur colloid particles are phagocytized by reticuloendothelial (RES) cells: Kupffer cells (liver), spleen macrophages, and bone marrow. Biodistribution is liver > spleen > marrow in normal adults. Particle size determines which application:

Preparation Particle size concept Primary uses

Unfiltered sulfur colloid Larger particles Liver-spleen scan; bone marrow imaging; GI bleeding (historical/alternate); gastric emptying meal label

  • Filtered sulfur colloid Smaller particles Lymphoscintigraphy / sentinel node mapping
  • Indications and Notes

Liver-spleen scan assesses size, colloid shift (increased spleen/marrow uptake in cirrhosis), and focal defects (nonspecific without correlation). Gastric emptying labels a standardized solid meal (commonly egg) with sulfur colloid and reports percent retention or emptied at timed points; solid and liquid protocols differ. Filtered colloid is injected intradermally or interstitially for lymphoscintigraphy / sentinel-node mapping (compare with tilmanocept). Some labs also use liquid sulfur colloid for reflux or aspiration studies. Adult liver-spleen activity is often ~4–6 mCi IV; meal doses are lower and meal-specific. Prep traps: boiling/kit errors that change particle size; free Tc to thyroid/stomach; never administer an interstitial lymph preparation as an IV liver-spleen dose.

  • Tc-99m Pertechnetate (TcO₄⁻)
  • Mechanism

Sodium pertechnetate is the eluate chemical form. It is handled like iodide by the sodium-iodide symporter for trapping in thyroid and salivary glands but is not organified —so it is not a true long-term thyroid hormone pathway agent like I-123/I-131. Gastric mucosa also concentrates pertechnetate—basis of Meckel’s scanning for ectopic gastric mucosa.

Indications

  • Study Role of pertechnetate Typical adult activity (approx.)
  • Meckel’s diverticulum Hot focus in RLQ/ectopic gastric mucosa ~8–12 mCi IV
  • Thyroid imaging / uptake adjunct Trapping map; less ideal than I-123 for many diagnoses ~2–10 mCi (protocol)
  • Salivary / lachrymal Gland function/patency studies Protocol-dependent
  • Testicular (historical) Blood flow/perfusion patterns Protocol-dependent
  • RBC labeling Source of Tc for UltraTag/in vivo methods As required for kit
  • Meckel’s and Thyroid Traps

Premedication protocols (cimetidine to reduce washout, pentagastrin to stimulate uptake, glucagon to decrease bowel motility—lab-specific combinations) aim to improve sensitivity for ectopic gastric mucosa. Time sequential images carefully; do not confuse bladder activity or normal stomach with a Meckel’s focus—use lateral/oblique views when needed. Recent barium studies or active bleeding can confound. Pertechnetate shows thyroid trapping only , not organification; discordance with radioiodine can occur in organification defects. Many cancer/met workups still prefer iodine isotopes, but CNMT items still test pertechnetate’s gastric and thyroid trapping behavior.

Side-by-Side Comparison

  • Agent Key mechanism Flagship indication
  • Mebrofenin Hepatocyte uptake → bile excretion Acute cholecystitis / biliary leak
  • Sulfur colloid RES phagocytosis Liver-spleen; gastric emptying; filtered lymph
  • Pertechnetate NIS trapping / gastric mucosa Meckel’s; thyroid trapping

NPO + nonvisualized GB → HIDA. Egg meal emptying → sulfur colloid. Child with painless bleeding / ectopic gastric mucosa → pertechnetate Meckel’s.